Jimin Xu

sun yat -sen university

H指数:31

被引数:2,975

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Drug Discovery of Antiviral Inhibitors Targeting Dengue Virus NS4B Protein

靶向登革病毒NS4B蛋白的抗病毒抑制剂药物发现

ACS Infectious Diseases

IF3.8

2026-04-210

PRE

Ablations of Human and Murine TNK2/ACK1 Proteins Do Not Alter Influenza A Virus Infections In Vitro or In Vivo

人源和鼠源TNK2/ACK1蛋白的敲除不影响体内或体外流感A病毒的感染

Journal of Medical Virology

IF4.6

2025-09-040

PRE

Small-Molecule Strategies against Human Adenoviruses: Progress; Challenges; and Future Perspectives

抗人腺病毒的小分子策略：进展；挑战；及未来展望

Journal of Medicinal Chemistry

IF6.8

2025-06-210

PRE

Salicylamide derivatives as potent HBV inhibitors: insights into structure-activity relationships

水杨酰胺衍生物作为强效HBV抑制剂：对构效关系的见解

RSC MEDICINAL CHEMISTRY

IF3.6

2025-01-010

PRE

Development of HJC0152, its analogs and protein degraders to modulate STAT3 for triple-negative breast cancer therapy

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Therapeutic potential of salicylamide derivatives for combating viral infections

MEDICINAL RESEARCH REVIEWS

IF11.6

2023-03-106

Design, synthesis, and pharmacological evaluations of pyrrolo[1,2-a] quinoxaline-based derivatives as potent and selective sirt6 activators

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2023-01-0113

OAAI

Th17 Cell-Derived Amphiregulin Promotes Colitis-Associated Intestinal Fibrosis Through Activation of mTOR and MEK in Intestinal Myofibroblasts

Th17细胞衍生的双调蛋白通过激活肠肌成纤维细胞中的mTOR和MEK促进结肠炎相关的肠纤维化

GASTROENTEROLOGY

IF25.1

2023-01-0135

In vitro and in vivo characterization of erythrosin B and derivatives against Zika virus

ACTA PHARMACEUTICA SINICA B

IF14.6

2022-04-0112

OAAI

Structure-activity relationship studies on O-alkylamino-tethered salicylamide derivatives with various amino acid linkers as potent anticancer agents

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2022-04-011

OAAI

Antiviral Agents against Flavivirus Protease: Prospect and Future Direction

PATHOGENS

IF3.3

2022-02-2527

OAAI

Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance

冬凌草甲素及其衍生物用于癌症治疗和克服治疗抗性

GENES & DISEASES

IF9.4

2021-07-0171

OAAI

Substituted N-(4-amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide analogues potently inhibit respiratory syncytial virus (RSV) replication and RSV infection-associated inflammatory responses

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2021-06-017

OAAI

Small-molecule inhibitors for the Prp8 intein as antifungal agents

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2021-01-0419

Drug repurposing approach to combating coronavirus: Potential drugs and drug targets

药物再利用方法来对抗冠状病毒: 潜在的药物和药物目标

MEDICINAL RESEARCH REVIEWS

IF11.6

2020-12-0527

OAAI

Discovery of Novel Substituted N-(4-Amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide Analogues as Potent Human Adenovirus Inhibitors

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2020-10-2815

PREAI

STING controls intestinal homeostasis through promoting antimicrobial peptide expression in epithelial cells

STING通过促进上皮细胞中抗菌肽的表达来控制肠道稳态

FASEB JOURNAL

IF4.2

2020-09-2425

OAAI

JMX0207, a Niclosamide Derivative with Improved Pharmacokinetics, Suppresses Zika Virus Infection Both In Vitro and In Vivo

ACS INFECTIOUS DISEASES

IF3.8

2020-09-0136

OAAI

Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential

广谱抗病毒药物氯硝柳胺及其治疗潜力

ACS INFECTIOUS DISEASES

IF3.8

2020-03-03248

OAAI

Structure-Activity Relationship Studies on Diversified Salicylamide Derivatives as Potent Inhibitors of Human Adenovirus Infection

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2020-02-1113

PREAI

Jimin Xu

个人简介

教育背景

工作经历

荣誉奖项

研究方向